Search results
- Valuation metrics show that Gossamer Bio, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of GOSS, demonstrate its potential to underperform the market. It currently has a Growth Score of D.
www.zacks.com › stock › research
People also ask
What's a good price target for Goss (Goss)?
Is Goss (Goss) stock a good buy?
Is gossamer bio (Goss) a good stock to buy?
Is Koss Corporation (Koss) a good stock to buy?
5 days ago · Zacks' proprietary data indicates that Gossamer Bio, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the GOSS shares relative to the market in the next few...
4 days ago · Forecast. Profile. Chart. 1D. 5D. 1M. YTD. 1Y. 5Y. Max. -4.93% ( 1D) News. All. Videos. Press Releases. Conversation. Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference.
5 days ago · 5 brokers have issued twelve-month price objectives for Gossamer Bio's shares. Their GOSS share price targets range from $1.25 to $15.00. On average, they predict the company's share price to reach $7.65 in the next year. This suggests a possible upside of 1,002.3% from the stock's current price.
- (858) 684-1300
- 3013 SCIENCE PARK, SAN DIEGO CA, 92121
- ir@gossamerbio.com
Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mountain-Chart. Compare with. Remove all. Compare with up to 5 Stocks. On Thursday morning 05/09/2024 the Gossamer Bio Inc Registered Shs share started trading at the price of $0.76. Compared to...
May 15, 2024 · GOSS Stock Price Quote | Morningstar. Stocks. Gossamer Bio Inc GOSS. Morningstar Rating. Unlock. Stock XNAS Rating as of May 15, 2024. Summary. Chart. News. Price vs Fair Value....